JTCS Speed Up Your Browser
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukui, T.
Right arrow Articles by Mitsudomi, T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Fukui, T.
Right arrow Articles by Mitsudomi, T.
Related Collections
Right arrow Lung - cancer

J Thorac Cardiovasc Surg 2008;136:1343-1348
© 2008 The American Association for Thoracic Surgery

General Thoracic Surgery

Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non–small cell lung cancers

Takayuki Fukui, MD*, Shoichi Mori, MD, Shunzo Hatooka, MD, Masayuki Shinoda, MD, Tetsuya Mitsudomi, MD

Department of Thoracic Surgery, Aichi Cancer Center Hospital, Nagoya, Japan

Received for publication September 21, 2007; revisions received December 4, 2007; accepted for publication December 18, 2007.

* Address for reprints: Takayuki Fukui, MD, Department of Thoracic Surgery, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-Ku, Nagoya 464-0021, Japan. (Email: tfukui{at}aichi-cc.jp).

Objective: The TNM classification has been widely used as a guide for estimating prognosis and is the basis for treatment decisions on various solid tumors. The International Association for the Study of Lung Cancer Staging Committee has proposed a new staging system for the next revision scheduled in 2009. However, its validity has not been established fully. Here we assessed its utilities and drawbacks.

Methods: We reviewed 1556 consecutive patients with non–small cell lung cancers who underwent pulmonary resection in our institution and reviewed their survival characteristics based on the 2009 system compared with the current (1997) system.

Results: The numbers of patients with stage IIA disease increased remarkably when using the 2009 system because of the reclassification of stages IB and IIB. Although the 5-year survival rates of the patients with stage IB and IIA disease in the 1997 system showed no difference with the 2009 system, the survival rates of patients with stage IB disease was 68.0%, which is better than that of patients with stage IIA disease (57.6%). The patient survival curves showed stepwise deterioration as the numbers increased, except for patient with stage IV disease.

Conclusions: Our study supported the proposal for this new staging system. Compared with the 1997 system, the 2009 system appears to be superior in separating stage IB and IIA disease and provides an even distribution among the stage groupings, although it is slightly complicated. The survival characteristics of 1556 resected cases in this single Japanese institution validated the proposed 2009 system.

Abbreviations and Acronyms BAC = bronchioloalveolar carcinoma; IASLC = International Association for the Study of Lung Cancer






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The American Association for Thoracic Surgery.